DK 46763/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	1
1994	1
1995	1
1996	1
1997	1
1998	2
1999	4
2000	2
2001	1
2002	2
2003	3
2004	1
2006	4
2007	4
2008	6
2009	3
2014	1
2024	0

1

Immunomodulator therapy in inflammatory bowel disease.

Choi PM, Targan SR. Choi PM, et al. Dig Dis Sci. 1994 Sep;39(9):1885-92. doi: 10.1007/BF02088121. Dig Dis Sci. 1994. PMID: 7521821 Review.

2

Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model.

De Winter H, Cheroutre H, Kronenberg M. De Winter H, et al. Am J Physiol. 1999 Jun;276(6):G1317-21. doi: 10.1152/ajpgi.1999.276.6.G1317. Am J Physiol. 1999. PMID: 10362634 Review.

3

Early microbial markers of celiac disease.

Viitasalo L, Niemi L, Ashorn M, Ashorn S, Braun J, Huhtala H, Collin P, Mäki M, Kaukinen K, Kurppa K, Iltanen S. Viitasalo L, et al. J Clin Gastroenterol. 2014 Aug;48(7):620-4. doi: 10.1097/MCG.0000000000000089. J Clin Gastroenterol. 2014. PMID: 24518796 Free PMC article.

4

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.

Papadakis KA, Yang H, Ippoliti A, Mei L, Elson CO, Hershberg RM, Vasiliauskas EA, Fleshner PR, Abreu MT, Taylor K, Landers CJ, Rotter JI, Targan SR. Papadakis KA, et al. Inflamm Bowel Dis. 2007 May;13(5):524-30. doi: 10.1002/ibd.20106. Inflamm Bowel Dis. 2007. PMID: 17260364

5

Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD.

Iltanen S, Tervo L, Halttunen T, Wei B, Braun J, Rantala I, Honkanen T, Kronenberg M, Cheroutre H, Turovskaya O, Autio V, Ashorn M. Iltanen S, et al. Inflamm Bowel Dis. 2006 May;12(5):389-94. doi: 10.1097/01.MIB.0000218765.84087.42. Inflamm Bowel Dis. 2006. PMID: 16670528

6

CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.

Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR. Papadakis KA, et al. Gastroenterology. 2001 Aug;121(2):246-54. doi: 10.1053/gast.2001.27154. Gastroenterology. 2001. PMID: 11487533

7

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H. Abreu MT, et al. Gastroenterology. 2002 Sep;123(3):679-88. doi: 10.1053/gast.2002.35393. Gastroenterology. 2002. PMID: 12198692

8

Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa.

Papadakis KA, Prehn J, Zhu D, Landers C, Gaiennie J, Fleshner PR, Targan SR. Papadakis KA, et al. Inflamm Bowel Dis. 2004 Nov;10(6):778-88. doi: 10.1097/00054725-200411000-00013. Inflamm Bowel Dis. 2004. PMID: 15626897

9

The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.

Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR. Papadakis KA, et al. J Immunol. 2000 Nov 1;165(9):5069-76. doi: 10.4049/jimmunol.165.9.5069. J Immunol. 2000. PMID: 11046037

10

B cell developmental requirement for the G alpha i2 gene.

Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J. Dalwadi H, et al. J Immunol. 2003 Feb 15;170(4):1707-15. doi: 10.4049/jimmunol.170.4.1707. J Immunol. 2003. PMID: 12574334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year